Here are relevant reports on : endovascular-stents-market
-
Gastrointestinal Stent Market by Product (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents and Esophageal Stents), Material (Self-Expanding Metal Stents and Plastic Stents), Application, End User & Region - Global Forecast to 2026
The size of global gastrointestinal stent market in terms of revenue was estimated to be worth $457 million in 2021 and is poised to reach $600 million by 2026, growing at a CAGR of 5.6% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Drug Eluting Stents Market - 2019 By Types, Application & Geography
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029
The global peripheral vascular devices market, valued at US$10.94B in 2023, is forecasted to grow at a 5.2% CAGR, reaching US$11.43B by 2024 and US$14.73B by 2029. Several factors drive growth in this peripheral vascular devices market. A pertinent factor is the incidence of peripheral artery disease and other vascular diseases, which is rising, primarily because of an aging population but also due to risk factors such as diabetes, hypertension, and obesity.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022
Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Interventional Cardiology Devices Market by Type (Stents, Structural Heart Devices, Angioplasty Balloons (Drug-Eluting), Angiography Catheters, Plaque Modification Devices (Thrombectomy Devices), Guidewires, Introducer Sheaths) - Global Forecast to 2029
The global interventional cardiology devices market, valued at US$26.32B in 2023, is forecasted to grow at a 6.0% CAGR, reaching US$27.80B by 2024 and US$37.27B by 2029. The growth in the interventional cardiology devices market is mainly due to an increase in CVDs across the world, the aging population, and the growing prevalence of risk factors like diabetes, hypertension, obesity, and sedentary lifestyle.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecasts to 2024
The lung stent market is projected to reach USD 120 million by 2024, at a CAGR of 6.7%. The major players operating in the lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Bioabsorbable Stents Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022
The global bioresorbable stents market is projected to reach USD 417.2 Million by 2022, at a CAGR of 11.5%. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth. The bioresorbable stents screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User, and Region - Global Forecast to 2028
The global urology devices market, valued at US$32.6B in 2022, is forecasted to grow at a 7.3% CAGR, reaching US$34.1B by 2023 and US$48.6B by 2028. Investments by hospitals in procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices.
- Published: November 2023
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
